Real-time enrollment status for this chronic graft-versus-host-disease clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:44 PM UTC
| NCT Number | NCT04710576 |
| Recruiting Status | Recruiting |
| Condition | Chronic Graft-versus-host-disease |
| Phase | PHASE2 |
| Target Enrollment | 296 participants |
| Active Locations | 47 sites in the US |
| Sponsor | Syndax Pharmaceuticals |
| Last Updated on CT.gov | June 16, 2026 (Jun 16, 2026) |
As of October 12, 2026: Clinical trial NCT04710576 is currently recruiting participants. This phase2 study for chronic graft-versus-host-disease is actively seeking new participants at 47 locations across the United States. The study is sponsored by Syndax Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04710576 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 47 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04710576 was last updated Jun 16, 2026 (June 16, 2026). HelloStudys verifies this status automatically.